Molecular Templates, Inc. Provides Interim Update
AUSTIN, Texas, June 03, 2024 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage company focused...
Month: June 2024
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
The advanced video payload for drones will be based on Maris-Tech’s Uranus technologyRehovot, Israel, June 03, 2024 (GLOBE NEWSWIRE) --...
Maris-Tech Receives New Order for $225,000 From a Military Drone Manufacturer for a Unique Solution for Unmanned Aircraft Systems
The advanced video payload for drones will be based on Maris-Tech’s Uranus technologyRehovot, Israel, June 03, 2024 (GLOBE NEWSWIRE) --...
Moderna & Merck Announce 3-Year Data For mRNA-4157 (V940) in Combination With KEYTRUDA(R) (pembrolizumab) Demonstrated Sustained Improvement in Recurrence-Free Survival & Distant Metastasis-Free Survival Versus KEYTRUDA in Patients With High-Risk Stage
At a median planned follow-up of the Phase 2b study at 34.9 months, mRNA-4157 (V940) in combination with KEYTRUDA reduced...
Modular Medical Announces Addition to the Russell Microcap(R) Index
SAN DIEGO, CA / ACCESSWIRE / June 3, 2024 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical"), a development-stage, insulin delivery...
Lattice Semiconductor Appoints Esam Elashmawi Interim Chief Executive Officer
President and Chief Executive Officer Jim Anderson Steps Down to Pursue a New Opportunity Contacts INVESTORS: Rick Muscha Lattice Semiconductor...
InnovAge PACE Recertified as a Great Place to Work
DENVER, June 03, 2024 (GLOBE NEWSWIRE) -- InnovAge Holding Corp. (“InnovAge”) (Nasdaq: INNV), an industry leader in providing comprehensive healthcare...
Frontier Announces Fiber Securitization Offering
Contacts Investor Spencer Kurn SVP, Investor Relations +1 401-225-0475 spencer.kurn@ftr.com Media Chrissy Murray VP, Corporate Communications +1 504-952-4225 chrissy.murray@ftr.com Frontier...
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
SOUTH SAN FRANCISCO, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Denali Therapeutics Inc. (Nasdaq: DNLI), a biopharmaceutical company developing a...
Coya Therapeutics Announces Acceptance of Peer-Reviewed Manuscript in the Medical Journal: Frontiers in Neurology
Expands on previously reported data showing the halting of disease progression in patients with ALS at six months and a...
Corcept Therapeutics Announces Presentations of Results of Pivotal Phase 3 GRACE Trial Evaluating Relacorilant in Patients with Hypercortisolism (Cushing’s Syndrome)
MENLO PARK, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the...
Promising Phase 2 Results For Biodexa’s eRapa(TM) Indicates Hope for FAP Patients Who Otherwise Have a 100% Lifetime Risk of Colorectal Cancer
CARDIFF, UK / ACCESSWIRE / June 3, 2024 / Biodexa Pharmaceuticals (NASDAQ:BDRX) just announced promising phase 2 results for its...
BriaCell Presents Clinical Efficacy Data at ASCO 2024
PHILADELPHIA and VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...
BriaCell Presents Clinical Efficacy Data at ASCO 2024
PHILADELPHIA and VANCOUVER, British Columbia, June 03, 2024 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell”...
Bio-Path Holdings Presents Ongoing Phase 2 Combination Study Data at ASCO Annual Meeting
DENVER, Colo., Jun 03, 2024 (247marketnews.com)- Maro Ohanian, D.O., Department of Leukemia, University of Texas MD Anderson Cancer Center, presented...
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
WARREN, N.J., June 03, 2024 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company...
Aptevo Participating in the BIO International Convention
SEATTLE, WA / ACCESSWIRE / June 3, 2024 / Aptevo Therapeutics Inc. (Nasdaq:APVO), a clinical-stage biotechnology company focused on developing...
Aethlon Medical Prepares for Potentially Transformative Phase 1 Cancer Treatment Studies
Phase 1 Clinical Trials of the Hemopurifier® Designed to Include Patients With Solid Tumors Who Have Stable or Progressive Disease...
Olympic Steel Welcomes Anthony Roberts as General Manager for Chambersburg, Pennsylvania, Facilities
Contacts Michelle Pearson-Casey Vice President, Corporate Communications & Marketing (216) 292-3800 Olympic Steel Inc. (Nasdaq: ZEUS), a leading national metals...
UroGen Pharma Appoints David Lin as New Chief Commercial Officer
Contacts INVESTOR CONTACT: Vincent Perrone Senior Director, Investor Relations vincent.perrone@urogen.com 609-460-3588 ext. 1093 MEDIA CONTACT: Cindy Romano Director, Corporate Communications...
TransAct Technologies Announces Update to Strategic Business Review
The Company is Actively Assessing Strategic Alternatives with Assistance from Roth Capital Partners, LLC Committee Formed to Support Review of...
Seven Hills Realty Trust Appoints Jared Lewis as Vice President
Contacts Stephen Colbert, Director, Investor Relations (617) 231-3223 Seven Hills Realty Trust (Nasdaq: SEVN) today announced that Jared Lewis has...
CHATHAM ASSET MANAGEMENT SENDS LETTER TO SINCLAIR REGARDING REFINANCING EFFORTS
CHATHAM, N.J., June 3, 2024 /PRNewswire/ -- Chatham Asset Management, LLC ("Chatham"), a private investment firm that through certain of its...
Rhythm Pharmaceuticals Announces Participation at Upcoming Investor Conference
BOSTON, June 03, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company focused on transforming the...
Replimune Presents Positive Data from RP1 and RP2 Clinical Programs at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
-- Investigator-assessed 12-month results from the IGNYTE clinical trial of RP1 plus nivolumab in anti-PD-1 failed melanoma demonstrate an overall...
PetMed Express, Inc. Announces Strategic Updates to Executive Leadership Team
Caroline Conegliano appointed Chief Operating OfficerUmesh Sripad appointed Chief Digital and Technology OfficerCompany Announces CFO transition Read more at globenewswire.com
PureCycle Provides Update on Ironton Purification Facility
IRONTON, OH / ACCESSWIRE / June 3, 2024 / PureCycle Technologies, Inc. (Nasdaq: PCT), today, announced that the Company's flagship...
Natera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
Contacts Investor Relations: Mike Brophy, CFO, Natera, Inc., 510-405-4709, investor@natera.com Media: Lesley Bogdanow, VP of Corporate Communications, Natera, Inc., pr@natera.com...
NKGen Biotech To Present Updated Phase 1 Data on SNK02 Allogeneic NK Cell Therapy in Solid Tumors at the 6th Annual Allogeneic Cell Therapies Summit 2024
SANTA ANA, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- NKGen Biotech, Inc. (Nasdaq: NKGN) (“NKGen” or the “Company”), a clinical-stage...
Neurocrine Biosciences Presented CAHtalyst™ Phase 3 Pediatric and Adult Studies, CAHtalog™ Registry and Disease- and Glucocorticoid-Related Comorbidities Data in CAH at ENDO 2024
SAN DIEGO, June 3, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) and Diurnal Ltd., a Neurocrine Biosciences company, presented...
Mainz Biomed Presented Industry Leading Results of its Pooled Study at ASCO 2024
New study data confirmed previous ColoFuture and eAArly DETECT study performance with sensitivity for CRC of 92% and 82% for...
23andMe Therapeutics Announces Positive Preliminary Phase 2 Safety and Efficacy Results for 23ME-00610, targeting CD200R1, at the 2024 ASCO Annual Meeting
– 23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit, including one confirmed partial response – 23ME-00610 monotherapy continues to demonstrate...
Mercantile Bank Corporation Implements Management Succession Plan
GRAND RAPIDS, Mich., June 3, 2024 /PRNewswire/ -- Mercantile Bank Corporation (NASDAQ: MBWM) implemented the following resignations and appointments, in...
Innovative Eyewear, Inc. to Participate in “Charting the Course: Navigating the Intersection of TMT and Business in the AI Era” Conference, June 4 – 5, 2024
MIAMI, June 3, 2024 /PRNewswire/ -- Innovative Eyewear, Inc. ("Innovative Eyewear" or "the Company") (Nasdaq: LUCY; LUCYW), the developer and seller of...
LANDSEA HOMES CLOSES ON 44 HOMESITES FOR A NEW COMMUNITY IN ANAHEIM, CA
ANAHEIM, Calif., June 3, 2024 /PRNewswire/ -- Landsea Homes Corporation (Nasdaq: LSEA) ("Landsea Homes" or the "Company"), a publicly traded...
aTyr Pharma Announces Nasdaq Stock Ticker Symbol Change from “LIFE” to “ATYR”
SAN DIEGO, June 03, 2024 (GLOBE NEWSWIRE) -- aTyr Pharma, Inc. (Nasdaq: LIFE) (“aTyr” or the “Company”), a clinical stage...
Industrial Logistics Properties Trust Appoints Marc Krohn as Vice President
Contacts Kevin Brady, Director, Investor Relations (617) 219-1489 Industrial Logistics Properties Trust (Nasdaq: ILPT) today announced that Marc Krohn has...
Fulgent Data at ASCO 2024 Highlights Antitumor Activity from Lead Therapeutic Oncology Candidate, FID-007, in Head and Neck Cancer
Contacts Investor Relations Contact The Blueshirt Group Melanie Solomon, melanie@blueshirtgroup.com Fulgent Pharma, a subsidiary of Fulgent Genetics, Inc. (NASDAQ: FLGT)...
Evaxion Presents Positive and Validating Immune Data from Ongoing Phase 2 Trial with AI-Designed EVX-01 Vaccine at the ASCO Annual Meeting 2024
COPENHAGEN, Denmark, June 03, 2024 (GLOBE NEWSWIRE) -- Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or the “Company”), a clinical-stage TechBio...
Enphase Energy Launches IQ Battery 5P in Canada
FREMONT, Calif., June 03, 2024 (GLOBE NEWSWIRE) -- Enphase Energy, Inc. (NASDAQ: ENPH), a global energy technology company and the...